Escorp Asset Management Ltd

Escorp Asset Mgt Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Escorp Asset Management Ltd

₹ 125 5.00%
29 Aug - close price
escorpamc.co.in BSE: 540455
About

Incorporated in 2011, Escorp Assset Management Ltd is in the business of portfolio management services

Key Points

Business Overview:[1]
Company is listed on BSE SME exchange and is a subsidiary company of Aryaman Financial Services Limited, which is the flagship company of the Aryaman Group. Aryaman Group is a Financial Services player having interests in Merchant Banking, Investment Banking, Corporate Advisory, Stock Broking, Market Making and Equity Investments

Website BSE
  • Market Cap ₹ 139 Cr.
  • Current Price ₹ 125
  • High / Low ₹ 125 / 45.0
  • Stock P/E 8.55
  • Book Value ₹ 60.0
  • Dividend Yield 0.00 %
  • ROCE 33.0 %
  • ROE 28.1 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company is almost debt free.

Cons

  • Though the company is reporting repeated profits, it is not paying out dividend
  • Tax rate seems low

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Financial Services Financial Services Finance Other Financial Services

Edit Columns
Loading peers table ...

Quarterly Results

Figures in Rs. Crores

Jun 2024 Mar 2025 Jun 2025
5.48 2.05 0.59
0.11 0.23 0.06
Operating Profit 5.37 1.82 0.53
OPM % 97.99% 88.78% 89.83%
0.30 0.32 0.34
Interest 0.00 0.00 0.00
Depreciation 0.00 0.00 0.00
Profit before tax 5.67 2.14 0.87
Tax % 12.17% 15.89% 16.09%
4.98 1.79 0.73
EPS in Rs 4.48 1.61 0.66
Raw PDF

Profit & Loss

Figures in Rs. Crores

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
0 0 0 1 0 0 0 0 6 2 20 20
0 0 0 0 0 0 0 0 0 0 0 0
Operating Profit 0 0 0 0 0 -0 0 0 6 2 20 19
OPM % 76% 38% -28% 6% 12% 97% 84% 99% 98%
0 0 0 0 0 0 0 0 0 0 0 0
Interest 0 0 0 0 0 0 0 0 0 0 0 0
Depreciation 0 0 0 0 0 0 0 0 0 0 0 0
Profit before tax 0 0 0 0 0 -0 0 0 6 2 20 19
Tax % 14% 10% 0% 0% 100% 5% 12% 12% 15%
0 0 0 0 0 -0 0 0 6 2 17 16
EPS in Rs 0.14 0.04 -0.04 0.00 0.00 3.17 1.58 15.52 14.64
Dividend Payout % 0% 0% 0% 0% 0% 0% 0%
Compounded Sales Growth
10 Years: %
5 Years: 162%
3 Years: 46%
TTM: -1%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: 41%
TTM: -6%
Stock Price CAGR
10 Years: %
5 Years: 85%
3 Years: 92%
1 Year: 75%
Return on Equity
10 Years: 17%
5 Years: 22%
3 Years: 25%
Last Year: 28%

Balance Sheet

Figures in Rs. Crores

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity Capital 0.01 0.01 0.01 5 7 7 7 7 7 11 11 11
Reserves 0 0 0 4 8 9 9 18 27 31 38 56
0 0 0 3 0 0 0 0 0 0 0 0
0 0 0 0 0 0 1 1 3 4 2 4
Total Liabilities 0 0 0 11 15 16 16 26 37 46 52 70
0 0 0 0 0 0 0 0 0 0 0 0
CWIP 0 0 0 0 0 0 0 0 0 0 0 0
Investments 0 0 0 8 12 15 16 26 32 39 37 50
0 0 0 3 3 0 1 0 5 7 15 20
Total Assets 0 0 0 11 15 16 16 26 37 46 52 70

Cash Flows

Figures in Rs. Crores

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
0 0 0 -0 -0 0 -0 0 6 1 17 15
0 0 0 -7 -0 -0 0 0 -2 1 -9 -10
0 0 0 8 1 0 0 0 0 0 0 0
Net Cash Flow 0 0 0 0 0 -0 0 0 4 2 8 5

Ratios

Figures in Rs. Crores

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtor Days 0 13 0 297 21 2 14 1 1
Inventory Days
Days Payable
Cash Conversion Cycle 0 13 0 297 21 2 14 1 1
Working Capital Days -1,889 201 175 365 215 -10 5 -1 4
ROCE % 0% 0% 0% 7% 1% -1% 0% 0% 21% 5% 43% 33%

Shareholding Pattern

Numbers in percentages

3 Recently
Mar 2020Sep 2020Mar 2021Sep 2021Mar 2022Sep 2022Mar 2023Sep 2023Mar 2024Sep 2024Mar 2025Jun 2025
67.62% 67.62% 67.62% 67.62% 67.62% 67.62% 67.62% 67.62% 67.62% 67.62% 67.62% 67.62%
32.38% 32.38% 32.38% 32.38% 32.38% 32.38% 32.38% 32.39% 32.39% 32.39% 32.39% 32.39%
No. of Shareholders 383941393840438684257255323

Documents

Announcements

Annual reports

DRHP